Holen Sie sich die Stockscreener-App
21.49
0.70%
0.15
Handel nachbörslich:
21.49
Überblick
Nachrichten
Preisverlauf
Optionskette
Warum fällt BCS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Barclays Plc Adr Aktie (BCS) Neueste Nachrichten
Barclays plc Conducts Routine Transaction Within Corporate Framework - Kalkine Media
Barclays Forecasts Strong Price Appreciation for Logitech International (NASDAQ:LOGI) Stock - Defense World
New Aerospike Workshops Deliver Hands-on Build of Real-Time Feature Stores for Predictive, Generative, and Agentic AI Apps - GlobeNewswire Inc.
Barclays PLC Executes Share Transaction within Capital Management Programme - Kalkine Media
Barclays PLC continues disciplined capital actions within the banking sector - Kalkine Media
Barclays PLC (NYSE:BCS) Receives Consensus Rating of “Buy” from Analysts - Defense World
Predictions - sharewise.com
WITTwo Sigma Investments 3Q 13F: Largest Eliminations - ADVFN
Barclays PLC (LSE:BARC) Confirms Completion of Share Transaction - Kalkine Media
RBC Capital Sticks to Its Buy Rating for Barclays (BARC) - The Globe and Mail
Barclays PLC Reports Strong Q3 2025 Earnings - The Globe and Mail
Alibaba Group Holding Ltd ADR diskutieren - sharewise.com
Barclays to cancel shares via £500m buy-back after £1,000m program - Stock Titan
Barclays Q3 Earnings Dip Y/Y as Costs, Credit Impairment Charges Rise - The Globe and Mail
Barclays Up Over 5%, on Pace for Largest Percent Increase Since April -- Data Talk - 富途牛牛
Barclays Financial Update Amid Charges – FTSE 100 Live - Kalkine Media
Barclays ADR earnings missed by $0.46, revenue fell short of estimates - Investing.com
HSBC Holdings (HSBA) Receives a Buy from Barclays - The Globe and Mail
REGBarclays PLC3rd Quarter Results - TradingView
IBN Q2 Earnings Rise Y/Y on Higher NII & Fee Incom, Stock Falls 5.9% - The Globe and Mail
Bank of America Upgraded, Allstate Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Kepler Capital Remains a Buy on Barclays (BARC) - The Globe and Mail
Morgan Stanley Reaffirms Their Buy Rating on Barclays (BARC) - The Globe and Mail
European, Asian stocks battered by U.S. regional bank worries - MarketWatch
Jefferies Keeps Their Buy Rating on Lloyds Banking (LLOY) - The Globe and Mail
Kepler Capital Sticks to Their Buy Rating for Lloyds Banking (LLOY) - The Globe and Mail
Barclays hits 52-week trading high as the stock continues to rally in 2025 - MSN
Barclays Keeps Their Buy Rating on AstraZeneca (AZN) - The Globe and Mail
Haleon PLC Sponsored ADR (HLN) Gets a Buy from Berenberg Bank - The Globe and Mail
Barclays Reaffirms Their Buy Rating on HSBC Holdings (HSBA) - The Globe and Mail
JEF Stock Slides on Revealing Exposure to Bankrupt First Brands Group - The Globe and Mail
Barclays discloses 3.94% stake in Dalata Hotel Group - Investing.com
Buy the Surge in AMD Stock After Striking Partnership with OpenAI? - The Globe and Mail
Morgan Stanley Remains a Buy on Barclays (BARC) - The Globe and Mail
Trading In London’s Blue Chip Stocks Is Surging — in New York - Bloomberg.com
Barclays files 2024 annual report with SEC - MSN
Case Updater: PCP v Barclays – Waiver of privilege | Latin America | Global law firm - Norton Rose Fulbright
Zacks Investment Ideas feature highlights: General Motors, Tesla, Ford, JPMorgan, Barclays, Citigroup, Goldman Sachs and UBS - The Globe and Mail
SEC Fair Fund Opens $25+ Payment Claims for Barclays Investors During 2019-2022 Trading Period - Stock Titan
GlaxoSmithKline (GSK) Gets a Hold from Barclays - The Globe and Mail
Barclays Sticks to Its Buy Rating for BP p.l.c. (BP) - The Globe and Mail
HSBC Vs. BCS: Which Foreign Bank Deserves A Spot In Your Portfolio? - Barchart.com
HSBC vs. BCS: Which Foreign Bank Deserves a Spot in Your Portfolio? - The Globe and Mail
Barclays discloses 3.87% position in Dalata Hotel Group - Investing.com
3rd UPDATE: Barclays 1st Half Net Profit +10% On Invest Bank; Shares Up - ADVFN
Rhumbline Advisers Reduces Stock Position in Barclays PLC $BCS - Defense World
Elon Musk Just Bought $1 Billion of Tesla Stock, Which Is Up 90% Since Lows Made in April. Is Now the Time for Investors to Go All In? - The Globe and Mail
MacroGenics (NASDAQ:MGNX) Now Covered by Analysts at Barclays - Defense World
Janux Therapeutics (NASDAQ:JANX) Now Covered by Barclays - Defense World
C4 Therapeutics (NASDAQ:CCCC) Now Covered by Barclays - Defense World
Summit Therapeutics (NASDAQ:SMMT) Coverage Initiated by Analysts at Barclays - Defense World
Ralph Lauren (NYSE:RL) Price Target Cut to $353.00 by Analysts at Barclays - Defense World
Merus (NASDAQ:MRUS) Now Covered by Barclays - Defense World
0.87%
0.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):